FACIOSCAPULOHUMERAL DYSTROPHY
Clinical trials for FACIOSCAPULOHUMERAL DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new FACIOSCAPULOHUMERAL DYSTROPHY trials appear
Sign up with your email to follow new studies for FACIOSCAPULOHUMERAL DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breakthrough drug trial offers hope for rare muscle disease
Disease control Recruiting nowThis study is testing an experimental drug called AOC 1020 for people with facioscapulohumeral muscular dystrophy (FSHD), a genetic condition that causes progressive muscle weakness. About 200 participants will receive either the drug or a placebo via IV infusion every six weeks …
Matched conditions: FACIOSCAPULOHUMERAL DYSTROPHY
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Scientists seek simpler way to track walking decline in muscle disease
Knowledge-focused Recruiting nowThis study aims to find easier ways to measure walking problems in adults with facioscapulohumeral muscular dystrophy (FSHD), a genetic muscle-wasting disease. Researchers will test if simple walking tests, like a 6-minute walk, give useful information compared to more complex, t…
Matched conditions: FACIOSCAPULOHUMERAL DYSTROPHY
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC